13.000
−2,26%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +130.2% | +89.5% | 3 / 3 | +224.1% | +1.23 pp | -1.09 pp | +14.5% | 0.00 | 4.63 | 1.644 | +224,1% | 44,0 | +130,2% | 4.63 | 15.32 | −69,7% |
| Pts | 12 | 12 | 12 | 12 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-19)EPS (TTM): 2.805
Financial charts
1.Revenue & growth
VND bn1.635Q2/26
1.Revenue & growth
VND bn1.635Q2/26
2.Profit & growth
VND bn44,0Q2/26
3.Profit mix (Penman)
VND bn162Q2/26
4.Margins & cost structure
%4.0%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn-38,8Q2/26
7.Asset structure
VND bn3.056Q2/26
8.Funding & debt health
VND bn · times3.056Q2/26
9.Revenue backlog
VND bn43,0Q2/26
10.Valuation
times · %4,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %956Q2/26
Adjusted EPS growth, latest quarter
130%
Average adjusted EPS growth, 3 quarters
89.5%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26